Where? Barcelona, Spain
The 3rd annual conference in Portfolio Management Strategies for Biosimilars and Generics bestows a place for pharmaceutical companies to share outlooks, concerns and impressions in a professional environment. We want to give you the means to apply new strategies to enter multiple markets with different regulations, strengthen commercial and marketing relationships, build strategic alliances, understand stakeholder's opinions and consider value-added generics and biosimilars markets to find less overcrowded and more profitable markets.
This annual event will also provide you with a great chance to not only benchmark with big Pharma companies but with successful small/mid-size ones that are thriving in an extremely competitive market. We wish not only to create a professional environment but a distended atmosphere where attendees are able to schedule one-to-one meetings with our exceptional speakers and meet peers who are willing to discuss their strategies and approaches in highly interactive roundtables, panel discussions and workshops.
The latest updates show that not many blockbuster drug's patents are about to expire and only a few companies in the top 20 generics market had a positive growth in the last year. The generics' market faces a stagnant future landscape. In this grey scenery, it is high time that pharmaceutical companies look after their portfolio.
Sandoz designing a combined portfolio of biosimilars and generics
Biocon evaluating the power of strategic alliances
- Accord Healthcare bringing together portfolio and project management
- CSA Healthcare evaluating the criteria for driving high valuable portfolios
- Gedeon Ritcher discussing the best marketing practices